Close

UPDATE: Aytu Biosciences (AYTU) PT Lowered to $5 at Cantor Fitzgerald, "Overweight" Rating Reiterated, Analyst Expects "Upwards Earnings Revisions Should Drive Shares Higher" May 17, 2022 06:13AM
Cantor Fitzgerald Reiterates Aytu Biosciences (AYTU) at Overweight, $11 PT, Sees it as Positive Development Potentially Extending ADHD Franchise Revenue Runway Mar 23, 2022 10:27AM
Cantor Fitzgerald Reiterates Overweight Rating on Aytu Biosciences (AYTU), Company's Transformation Remains Underappreciated Feb 15, 2022 06:00AM
Aytu BioScience's (AYTU) Experienced CFO Hire is a Positive For the Company - Cantor Fitzgerald Jan 4, 2022 11:11AM